Alaethes Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.91M | Buy |
10,304
+377
| +4% | +$70K | 0.57% | 59 |
|
2025
Q1 | $2.08M | Buy |
9,927
+953
| +11% | +$200K | 0.76% | 44 |
|
2024
Q4 | $1.59M | Buy |
8,974
+131
| +1% | +$23.3K | 0.57% | 62 |
|
2024
Q3 | $1.75M | Buy |
8,843
+863
| +11% | +$170K | 0.64% | 55 |
|
2024
Q2 | $1.37M | Sell |
7,980
-1,442
| -15% | -$247K | 0.57% | 69 |
|
2024
Q1 | $1.72M | Buy |
9,422
+7,546
| +402% | +$1.37M | 0.75% | 54 |
|
2023
Q4 | $291K | Buy |
+1,876
| New | +$291K | 0.14% | 101 |
|
2022
Q2 | – | Sell |
-363
| Closed | -$59K | – | 102 |
|
2022
Q1 | $59K | Buy |
363
+255
| +236% | +$41.4K | 0.04% | 134 |
|
2021
Q4 | $15K | Sell |
108
-25
| -19% | -$3.47K | 0.01% | 179 |
|
2021
Q3 | $14K | Hold |
133
| – | – | 0.01% | 173 |
|
2021
Q2 | $15K | Buy |
+133
| New | +$15K | 0.01% | 169 |
|